p38γ mitogen-activated protein kinase signals through phosphorylating its phosphatase PTPH1 in regulating Ras protein oncogenesis and stress response

Journal of Biological Chemistry

Volumn 287, Issue 33, 2012, Pages 27895-27905

  Hou, Songwang ^a   Suresh, Padmanaban S ^a   Qi, Xiaomei ^a   Lepp, Adrienne ^a   Mirza, Shama P ^a   Chen, Guan ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR ENVIRONMENT; COMPLEX FORMATIONS; IN-VITRO; MITOGEN ACTIVATED PROTEIN KINASE; NEW MECHANISMS; ONCOGENESIS; ONCOGENIC ACTIVITIES; PROTEIN-TYROSINE PHOSPHATASE; PROTEOMIC ANALYSIS; STRESS RESPONSE;

AMINO ACIDS; CELL DEATH; PHOSPHORYLATION;

PHOSPHATASES;

K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 12; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 3; RAS PROTEIN; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL FATE; CELL GROWTH; COLON CANCER; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 12; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 3; RAS PROTEINS; STRESS, PHYSIOLOGICAL;

EID: 84865009345     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.335794     Document Type: Article

References (52)

1. Raman, M., Chen, W., and Cobb, M. H. (2007) Differential regulation and properties of MAPKs. Oncogene 26, 3100-3112
2. Barr, A. J., and Knapp, S. (2006) MAPK-specific tyrosine phosphatases: new targets for drug discovery? Trends Pharmacol. Sci. 27, 525-530
3. Avruch, J. (2007) MAP kinase pathways: the first 20 years. Biochim. Biophys. Acta 1773, 1150-1160
4. Sun, H., Charles, C. H., Lau, L. F., and Tonks, N. K. (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487-493
5. Brondello, J. M., Pouysségur, J., and McKenzie, F. R. (1999) Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286, 2514-2517
6. Camps, M., Nichols, A., Gillieron, C., Antonsson, B., Muda, M., Chabert, C., Boschert, U., and Arkinstall, S. (1998) Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280, 1262-1265
7. Lin, Y. W., Chuang, S. M., and Yang, J. L. (2003) ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway. J. Biol. Chem. 278, 21534-21541
8. Lin, Y. W., and Yang, J. L. (2006) Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling. J. Biol. Chem. 281, 915-926
9. Lassar, A. B. (2009) The p38 MAPK family, a pushmi-pullyu of skeletal muscle differentiation. J. Cell Biol. 187, 941-943
10. Loesch, M., and Chen, G. (2008) The p38MAPKstress pathway as a tumor suppressor or more? Front. Biosci. 13, 3581-3593
11. Hou, S., Lepp, A., and Chen, G. (2010) p38γ MAP kinase. UCSD Nat. Mol. Pages, doi:1038/mp.a001720.01
12. Chen, G., Hitomi, M., Han, J., and Stacey, D. W. (2000) The p38 pathway provides negative feedback for Ras proliferative signaling. J. Biol. Chem. 275, 38973-38980
13. Qi, X., Tang, J., Pramanik, R., Schultz, R. M., Shirasawa, S., Sasazuki, T., Han, J., and Chen, G. (2004) p38 MAPK activation selectively induces cell death in K-Ras-mutated human colon cancer cells through regulation of vitamin D receptor. J. Biol. Chem. 279, 22138-22144
14. Bulavin, D. V., Phillips, C., Nannenga, B., Timofeev, O., Donehower, L. A., Anderson, C. W., Appella, E., and Fornace, A. J., Jr. (2004) Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16Ink4a-p19Arf pathway. Nat. Genet. 36, 343-350
15. Dolado, I., Swat, A., Ajenjo, N., De Vita, G., Cuadrado, A., and Nebreda, A. R. (2007) p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11, 191-205
16. Tang, J., Qi, X., Mercola, D., Han, J., and Chen, G. (2005) Essential role of p38γ in K-Ras transformation independent of phosphorylation. J. Biol. Chem. 280, 23910-23917
17. Qi, X., Pohl, N. M., Loesch, M., Hou, S., Li, R., Qin, J. Z., Cuenda, A., and Chen, G. (2007) p38α antagonizes p38γ activity through c-Jun-dependent ubiquitin-proteasome pathways in regulating Ras transformation and stress response. J. Biol. Chem. 282, 31398-31408
18. Hou, S. W., Zhi, H. Y., Pohl, N., Loesch, M., Qi, X. M., Li, R. S., Basir, Z., and Chen, G. (2010) PTPH1 dephosphorylates and cooperates with p38γ MAPK to increase Ras oncogenesis through PDZ-mediated interaction. Cancer Res. 70, 2901-2910
19. Qi, X., Tang, J., Loesch, M., Pohl, N., Alkan, S., and Chen, G. (2006) p38γ mitogen-activated protein kinase integrates signaling cross-talk between Ras and estrogen receptor to increase breast cancer invasion. Cancer Res. 66, 7540-7547
20. Loesch, M., Zhi, H. Y., Hou, S. W., Qi, X. M., Li, R. S., Basir, Z., Iftner, T., Cuenda, A., and Chen, G. (2010) p38γ MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9. J. Biol. Chem. 285, 15149-15158
21. Cuenda, A., Alonso, G., Morrice, N., Jones, M., Meier, R., Cohen, P., and Nebreda, A. R. (1996) Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells. EMBO J. 16, 4156-4164
22. Cuenda, A., Cohen, P., Buée-Scherrer, V., and Goedert, M. (1997) Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16, 295-305
23. Wu, C. C., Wu, X., Han, J., and Sun, P. (2010) p38γ regulates UV-induced checkpoint signaling and repair of UV-inducedDNAdamage. Protein Cell 1, 573-583
24. Kukkonen-Macchi, A., Sicora, O., Kaczynska, K., Oetken-Lindholm, C., Pouwels, J., Laine, L., and Kallio, M. J. (2011) Loss of p38γ MAPK induces pleiotropic mitotic defects and massive cell death. J. Cell Sci. 124, 216-227
25. Cuenda, A., and Cohen, P. (1999) Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 274, 4341-4346
26. Zhang, H., Meng, F., Liu, G., Zhang, B., Zhu, J., Wu, F., Ethier, S. P., Miller, F., and Wu, G. (2011) Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 71, 1292-1301
27. Meng, F., Zhang, H., Liu, G., Kreike, B., Chen, W., Sethi, S., Miller, F. R., and Wu, G. (2011) p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly(ADP-ribose)- polymerase-1 inhibition in breast cancer. Neoplasia 13, 472-482
28. Hasegawa, M., Cuenda, A., Spillantini, M. G., Thomas, G. M., Buée-Scherrer, V., Cohen, P., and Goedert, M. (1999) Stress-activated protein kinase-3 interacts with the PDZ domain of α1-syntrophin: a mechanism for specific substrate recognition. J. Biol. Chem. 274, 12626-12631
29. Sabio, G., Reuver, S., Feijoo, C., Hasegawa, M., Thomas, G. M., Centeno, F., Kuhlendahl, S., Leal-Ortiz, S., Goedert, M., Garner, C., and Cuenda, A. (2004) Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90/PSD-95 by activation of SAPK3/p38γ and ERK1/ERK2. Biochem. J. 380, 19-30
30. Sabio, G., Arthur, J. S., Kuma, Y., Peggie, M., Carr, J., Murray-Tait, V., Centeno, F., Goedert, M., Morrice, N. A., and Cuenda, A. (2005) p38γ regulates the localization of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J. 24, 1134-1145
31. Moscat, J., Diaz-Meco, M. T., Albert, A., and Campuzano, S. (2006) Cell signaling and function organized by PB1 domain interactions. Mol. Cell 23, 631-640
32. Smock, R. G., and Gierasch, L. M. (2009) Sending signals dynamically. Science 324, 198-203
33. Qi, X., Hou, S., Lepp, A., Li, R., Basir, Z., Lou, Z., and Chen, G. (2011) Phosphorylation and stabilization of topoisomerase IIα protein by p38γ mitogen-activated protein kinase sensitize breast cancer cells to its poisons. J. Biol. Chem. 286, 35883-35890
34. Mologni, L., Dekhil, H., Ceccon, M., Purgante, S., Lan, C., Cleris, L., Magistroni, V., Formelli, F., and Gambacorti-Passerini, C. B. (2010) Colorectal tumors are effectively eradicated by combined inhibition of β-catenin, K-Ras, and the oncogenic transcription factor ITF2. Cancer Res. 70, 7253-7263
35. Zhi, H. Y., Hou, S. W., Li, R. S., Basir, Z., Xiang, Q., Szabo, A., and Chen, G. (2011) PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization. Oncogene 30, 1706-1715
36. Qi, X., Borowicz, S., Pramanik, R., Schultz, R. M., Han, J., and Chen, G. (2004) Estrogen receptor inhibits c-Jun-dependent stress-induced cell death by binding and modifying c-Jun activity in human breast cancer cells. J. Biol. Chem. 279, 6769-6777
37. Dephoure, N., Zhou, C., Villén, J., Beausoleil, S. A., Bakalarski, C. E., Elledge, S. J., and Gygi, S. P. (2008) A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 105, 10762-10767
38. Hou, Z., Peng, H., White, D. E., Wang, P., Lieberman, P. M., Halazonetis, T., and Rauscher, F. J., 3rd. (2010) 14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation. Cancer Res. 70, 4385-4393
39. Zhang, S. H., Liu, J., Kobayashi, R., and Tonks, N. K. (1999) Identification of the cell cycle regulator VCP (p97/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1. J. Biol. Chem. 274, 17806-17812
40. He, J., Bellini, M., Xu, J., Castleberry, A. M., and Hall, R. A. (2004) Interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits β1-adrenergic receptor surface expression. J. Biol. Chem. 279, 50190-50196
41. Ozes, O., Blatt, L. M., and Seiwert, S. D. (August 5, 2008) U. S. Patent 7,407,973 B2, 1-46
42. Moran, N. (2011) p38 kinase inhibitor approved for idiopathic pulmonary fibrosis. Nat. Biotechnol. 29, 301
43. Qi, X., Zhi, H., Lepp, A., Wang, P., Huang, J., Basir, Z., Chitambar, C. R., Myers, C. R., and Chen, G. (2012) p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription. J. Biol. Chem. 287, 14681-14691
44. McLaughlin, M. M., Kumar, S., McDonnell, P. C., Van Horn, S., Lee, J. C., Livi, G. P., and Young, P. R. (1996) Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J. Biol. Chem. 271, 8488-8492
45. Kalmes, A., Deou, J., Clowes, A. W., and Daum, G. (1999) Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580. FEBS Lett. 444, 71-74
46. Owens, D. M., and Keyse, S. M. (2007) Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26, 3203-3213
47. Shin, S., Dimitri, C. A., Yoon, S. O., Dowdle, W., and Blenis, J. (2010) ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol. Cell 38, 114-127
48. Wagner, E. F., and Nebreda, A. R. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549
49. Tonks, N. K. (2005) Redox redux: revisiting PTPs and the control of cell signaling. Cell 121, 667-670
50. Cheung, P. C., Campbell, D. G., Nebreda, A. R., and Cohen, P. (2003) Feedback control of the protein kinase TAK1 by SAPK2a/p38α. EMBO J. 22, 5793-5805
51. Zhang, Y. Y., Wu, J. W., and Wang, Z. X. (2011) Mitogen-activated protein kinase (MAPK) phosphatase 3-mediated cross-talk between MAPKs ERK2 and p38α. J. Biol. Chem. 286, 16150-16162
52. Jurek, A., Amagasaki, K., and Gembarska, A. (2009) Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced ERK activation. J. Biol. Chem. 284, 4626-4634